On Thursday, the Food and Drug Administration (FDA) publicly called out companies charged with blocking the development of generic drugs. According to generic manufacturers, brand name manufacturers ...
The only way to boost a price by more than 5,000% is to bend the laws of supply and demand in your favor. Turing Pharmaceuticals and its infamous chief executive, Martin Shkreli, presumably knew this ...
SILVER SPRING, Md., Nov. 21, 2017 /PRNewswire-USNewswire/ -- As we continue to confront the staggering human and economic toll created by opioid abuse and addiction, we're focused on taking actions ...
Photo courtesy of starline on Freepik. Opinions expressed by Digital Journal contributors are their own. Santosh Kesarpu has established expertise in complex generic formulation, applying rigorous ...
Defining the steps involved in a successful technology transfer process would benefit biopharma, say the researchers behind a “generic” blueprint intended to help drug makers move more easily from ...
The Chosun Ilbo on MSN
Obesity drug patents expire, generics drive market shift
The key component of Wegovy, which leads the global obesity treatment market, semaglutide, is losing patent protection in ...
In October 2011, drug shortages were such a pressing issue in the U.S. that President Barack Obama issued an executive order urging the Food & Drug Administration to streamline the approval process ...
Designing an efficient platform is crucial for any industrial process. This design process is known as process development, and it has become increasingly important in the pharmaceutical industry at ...
The U.S. Food and Drug Administration today approved the first generic version of EpiPen and EpiPen Jr (epinephrine) auto-injector for the emergency treatment of allergic reactions, including those ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results